It has been a couple of month for the reason that final earnings report for HealthEquity (HQY). Shares have misplaced about 2.2% in that time-frame, outperforming the S&P 500.
Will the current adverse development proceed main as much as its subsequent earnings launch, or is HealthEquity due for a breakout? Earlier than we dive into how buyers and analysts have reacted as of late, let’s take a fast take a look at its most up-to-date earnings report as a way to get a greater deal with on the vital catalysts.
How Have Estimates Been Transferring Since Then?
It seems, estimates revision have trended downward in the course of the previous month.
The consensus estimate has shifted -8.99% as a consequence of these modifications.
VGM Scores
At present, HealthEquity has a pleasant Development Rating of B, although it’s lagging loads on the Momentum Rating entrance with an F. Charting a considerably comparable path, the inventory was allotted a grade of D on the worth aspect, placing it within the backside 40% for this funding technique.
General, the inventory has an combination VGM Rating of D. In the event you aren’t targeted on one technique, this rating is the one you need to be thinking about.
Outlook
Estimates have been broadly trending downward for the inventory, and the magnitude of those revisions signifies a downward shift. Notably, HealthEquity has a Zacks Rank #3 (Maintain). We anticipate an in-line return from the inventory within the subsequent few months.
Solely $1 to See All Zacks’ Buys and Sells
We’re not kidding.
A number of years in the past, we shocked our members by providing them 30-day entry to all our picks for the entire sum of solely $1. No obligation to spend one other cent.
1000’s have taken benefit of this chance. 1000’s didn’t – they thought there have to be a catch. Sure, we do have a purpose. We would like you to get acquainted with our portfolio companies like Shock Dealer, Shares Underneath $10, Expertise Innovators,and extra, that closed 256 positions with double- and triple-digit positive aspects in 2024 alone.
HealthEquity, Inc. (HQY) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
The views and opinions expressed herein are the views and opinions of the creator and don’t essentially replicate these of Nasdaq, Inc.
